Global Public Health Partnering 2014 – 2019 Market Research Report

 Breaking News
  • No posts were found

Global Public Health Partnering 2014 – 2019 Market Research Report

September 03
09:20 2019
Global Public Health Partnering 2014 - 2019 Market Research Report

Global Public Health Partnering 2014 – 2019
MarketResearchReports.com has announced the addition of “Global Public Health Partnering 2014-2019: Deal trends, players and financials” research report to their website www.MarketResearchReports.com

Global Public Health Partnering 2014 to 2019 provides the full collection of Public Health disease deals signed between the worlds pharmaceutical and biotechnology companies since 2014.

 

Trends in Public Health partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Public Health partnering agreement structure

Public Health partnering contract documents

Top Public Health deals by value

Most active Public Health dealmakers

 

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

 

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

 

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

 

Please visit this link for more details: https://www.marketresearchreports.com/current-partnering/global-public-health-partnering-2014-2019-deal-trends-players-and-financials

 

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

 

Chapter 1 provides an introduction to the report.

 

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

 

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

 

Chapter 4 provides a review of the leading Public Health deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

 

Chapter 5 provides comprehensive access to Public Health deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

 

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2014. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2014.

 

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

 

Report scope

 

Global Public Health Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

 

Global Public Health Partnering 2014 to 2019 includes:

 

Trends in Public Health dealmaking in the biopharma industry since 2014

Analysis of Public Health deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Public Health deal contract documents

Comprehensive access to over 200 Public Health deal records

The leading Public Health deals by value since 2014

Most active Public Health dealmakers since 2014

 

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

 

In Global Public Health Partnering 2014 to 2019, available deals and contracts are listed by:

 

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

 

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

The Global Public Health Partnering 2014-2019 report provides comprehensive access to available deals and contract documents for over 200 public health deals. Analyzing actual contract agreements allows assessment of the following:

 

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

 

Benefits

Global Public Health Partnering 2014 to 2019 provides the reader with the following key benefits:

 

In-depth understanding of Public Health deal trends since 2014

Access Public Health deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Public Health partner companies

Comprehensive access to over 200 links to actual Public Health deals entered into by the world’s biopharma companies

Indepth review of Public Health deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Public Health opportunities

Uncover companies actively partnering Public Health opportunities

 

Spanning over 170 pages “Global Public Health Partnering 2014-2019: Deal trends, players and financialsreport covers Introduction, Trends in Public Health dealmaking, Financial deal terms for Public Health partnering, Leading Public Health deals and dealmakers, Public Health contract document directory, Public Health dealmaking by therapeutic target.

 

Please visit this link for more details: https://www.marketresearchreports.com/current-partnering/global-public-health-partnering-2014-2019-deal-trends-players-and-financials

 

Find all Deals & Alliances (Pharma & Healthcare) Reports at:   https://www.marketresearchreports.com/deals-alliances-pharma-healthcare `

 

Read our Interactive Market Research Blog

 

About MarketResearchReports.com

MarketResearchReports.com is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

 

Press Contact:
Mr. Sudeep Chakravarty
Director – Operations
MarketResearchReports.com

USA: +1-302-703-9904

 

Contact us for your market research requirements: https://www.marketresearchreports.com/contact

Media Contact
Company Name: MarketResearchReports.com
Contact Person: Sudeep Chakravarty
Email: Send Email
Phone: +1-302-703-9904
Address:16192 Coastal Hwy
City: Lewes
State: Delaware
Country: United States
Website: www.marketresearchreports.com

Calendar

September 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Categories